Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of ZD1839 and Radiation in Patients With Squamous Cell Carcinoma of the Skin

NCT00126555 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00126555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00126555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of ZD1839 and Radiation in Patients With Squamous Cell Carcinoma of the Skin
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2005
Completion date
February 28, 2013
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent skin cancer, squamous cell carcinoma of the skin